Sono-Tek (SOTK) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
3 Feb, 2026Executive summary
Achieved record annual revenue of $20.5 million in FY 2025, up 4% year-over-year, with net income of $1.27 million, maintaining profitability despite a challenging environment.
Strategic focus on high-ASP, complex systems for clean energy, medical, and semiconductor markets drove growth and expanded addressable market.
Backlog at fiscal year-end was $8.67 million, including the largest orders in company history, supporting near-term revenue visibility.
Growth driven by high ASP system shipments, especially in alternative/clean energy and medical device markets.
Financial highlights
Net sales increased 4% to $20.5 million compared to $19.7 million in FY 2024.
Gross profit for FY 2025 was $9.74 million, down 1% year-over-year; gross margin decreased to 47.5% from 50%.
Operating income declined to $1.01 million from $1.18 million, and net income was $1.27 million ($0.08/share) versus $1.44 million ($0.09/share) prior year.
Cash and marketable securities totaled $11.9 million with no debt; CapEx was $496,000 for facility upgrades.
Fourth quarter net sales rose 7.4% year-over-year to $5.12 million; net income more than doubled to $328,000.
Outlook and guidance
Expects continued revenue growth and profitability in the first half of FY 2026, supported by backlog and new orders.
Visibility for the second half of FY 2026 is limited, with potential softness in clean energy but offset by opportunities in medical and semiconductor sectors.
Guidance will be revisited with Q1 FY 2026 results.
Eight clean energy systems in backlog are expected to ship in Q1 and Q2 of FY 2026.
Latest events from Sono-Tek
- Leadership in ultrasonic coatings, global reach, and scalable solutions drive growth.SOTK
Planet MicroCap Showcase: VEGAS 20253 Feb 2026 - Record backlog and clean energy demand drive double-digit first half growth and profitability.SOTK
Q2 202519 Jan 2026 - Record backlog and 50% gross margin drive 24% net income growth despite flat sales.SOTK
Q3 202613 Jan 2026 - Record backlog and high-value system sales drive growth in clean energy and tech markets.SOTK
21st Virtual Investor Summit Microcap Event13 Jan 2026 - Record revenue, 150% medical sales growth, and 50% backlog increase offset sector declines.SOTK
Q2 20267 Jan 2026 - Proxy covers director elections, auditor ratification, and executive pay, with focus on governance and oversight.SOTK
Proxy Filing1 Dec 2025 - Proxy covers director elections, auditor change, executive pay, and board governance.SOTK
Proxy Filing1 Dec 2025 - Net income rose 47% to $485K as gross margin hit 52% on strong clean energy demand.SOTK
Q1 202610 Jul 2025 - Net income surged on 40% sales growth, led by medical and clean energy demand.SOTK
Q1 202513 Jun 2025